Medicare Enrolled

Dr. Muhammad Munir, MD

Cardiovascular Disease · Royal Oak, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4045 W 13 MILE RD STE B4, Royal Oak, MI 48073
2482886800
In practice since 2006 (20 years)
NPI: 1124079553 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Munir from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Munir? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Munir

Dr. Muhammad Munir is a cardiovascular disease specialist in Royal Oak, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Munir performed 2,822 Medicare services across 1,618 unique beneficiaries.

Between the years covered by Open Payments, Dr. Munir received a total of $7,227 from 34 pharmaceutical and/or device companies across 359 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Munir is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 18% volume in MI $7,227 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,822
Medicare services
Top 18% in MI for cardiovascular disease
1,618
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~141 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
504 $41 $70
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
476 $64 $105
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
401 $63 $108
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
227 $97 $164
Technetium Tc-99m sestamibi diagnostic injection
A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies.
211 $105 $225
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
192 $121 $427
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
131 $139 $398
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review.
123 $48 $225
Injection, dipyridamole, per 10 mg 120 $3 $10
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
119 $106 $258
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera.
111 $333 $860
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
76 $95 $135
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
44 $11 $49
Sedation by physician, initial 15 minutes
Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older.
26 $11 $34
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
26 $79 $135
Cardiac catheterization 18 $235 $841
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
17 $119 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.4% high complexity
24.7% medium
67.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,227
Total received (2018-2024)
Avg $1,032/year across 7 years
Top 29% in MI for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
359
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,227 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,570
2023
$1,576
2022
$987
2021
$1,154
2020
$609
2019
$728
2018
$604

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$384
Novartis Pharmaceuticals Corporation
$203
Lexicon Pharmaceuticals, Inc.
$148
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$131
Madrigal Pharmaceuticals
$108
Bayer Healthcare Pharmaceuticals Inc.
$103
GlaxoSmithKline, LLC.
$101
Merck Sharp & Dohme LLC
$86
Impulse Dynamics (USA) Inc.
$44
Janssen Pharmaceuticals, Inc
$44
Amgen Inc.
$38
Novo Nordisk Inc
$34
Lilly USA, LLC
$34
Boston Scientific Corporation
$33
PFIZER INC.
$30
SCPHARMACEUTICALS INC.
$30
E.R. Squibb & Sons, L.L.C.
$19
Top 3 companies account for 46.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,388
AstraZeneca Pharmaceuticals LP
$1,180
Janssen Pharmaceuticals, Inc
$609
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$597
Amgen Inc.
$359
PFIZER INC.
$357
Merck Sharp & Dohme LLC
$255
GlaxoSmithKline, LLC.
$235
Kestra Medical Technology Services, Inc.
$230
Bayer Healthcare Pharmaceuticals Inc.
$197
BOSTON SCIENTIFIC CORPORATION
$195
Lexicon Pharmaceuticals, Inc.
$166
Novo Nordisk Inc
$159
Boehringer Ingelheim Pharmaceuticals, Inc.
$131
Medtronic Vascular, Inc.
$114
Merck Sharp & Dohme Corporation
$109
Madrigal Pharmaceuticals
$108
Actelion Pharmaceuticals US, Inc.
$106
Bayer HealthCare Pharmaceuticals Inc.
$99
Regeneron Healthcare Solutions, Inc.
$87
Lilly USA, LLC
$83
E.R. Squibb & Sons, L.L.C.
$80
Esperion Therapeutics, Inc.
$54
Amarin Pharma Inc.
$46
Impulse Dynamics (USA) Inc.
$44
Kiniksa Pharmaceuticals, Ltd.
$42
ABIOMED
$34
Boston Scientific Corporation
$33
SCPHARMACEUTICALS INC.
$30
Preventice Services, LLC
$30
HeartFlow, Inc.
$18
Allergan, Inc.
$17
Mission Pharmacal Company
$16
MEDICOMP INC
$15
Top 3 companies account for 44.0% of all-time payments
Associated products mentioned in payments ›
AREXVY · Advisa · Arcalyst · Assure WCD · Azure · BREZTRI · BRILINTA · CAMZYOS · CHANTIX · Corlanor · ELIQUIS · EMBLEM · ENTRESTO · FARXIGA · FUROSCIX · Impella · Inpefa · JARDIANCE · Kerendia · LEQVIO · LUX DX · LifeVest · Micra · NEXLETOL · OPSUMIT MACITENTAN · Optimizer · Ozempic · PRALUENT · REZDIFFRA · Repatha · TELEPATCH CARDIAC MONITOR · TRELEGY ELLIPTA · TRULICITY · UBRELVY · VERQUVO · VYNDAQEL · Vascepa · WAINUA · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cardiovascular disease specialist in Royal Oak?
Compare cardiologists in the Royal Oak area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
315
Per 100K population
24.8
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL ROYAL OAK
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Munir is a clinical cardiology specialist, with above-average Medicare volume (top 18% in MI), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Munir experienced with hospital follow-up visit, low complexity?
Based on Medicare claims data, Dr. Munir performed 504 hospital follow-up visit, low complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Munir receive payments from pharmaceutical companies?
Yes. Dr. Munir received a total of $7,227 from 34 companies across 359 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Munir's costs compare to other cardiologists in Royal Oak?
Dr. Munir's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Munir) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →